Innovent Biologics (suzhou) Co. Ltd.

This study tested a new drug called IBI112 in 150 people with moderate to severe ulcerative colitis, a condition that causes inflammation and sores in the colon. The goal was to see if IBI112 could help patients reach clinical remission (no symptoms) after 12 weeks of treatment. …

This study tested a new drug, IBI129, in about 180 adults with advanced solid tumors that could not be removed by surgery. The main goals were to find the safest dose and to see if the drug can help control the cancer. The trial was completed and focused on safety and tumor respo…

This early-phase trial tested a new drug called IBI133 in 19 adults with advanced solid tumors that could not be removed by surgery. The main goals were to find a safe dose and see if the drug can shrink tumors. The study is now complete, and results will help guide future resear…

This study tested a new medicine called IBI311 for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. About 38 adults with active or inactive disease received different doses of the drug. The main goal was to see if it safely reduces eye bulg…

This early-stage study tested a single dose of a new drug called IBI3002 in 52 healthy volunteers and people with mild-to-moderate asthma. The main goal was to see if the drug is safe and how the body processes it. Researchers measured side effects and drug levels in the blood ov…